I seem to recall that Illucix 2.0 was being developed as part of a lifecycle management strategy for Illucix. I take it that you keep adding indications to Illucix, so that it’s a continually updated product and Telix keeps the rights to it, not allowing generics to start selling their latest and greatest version.
Now if that is true, the big question is what are the new indications?
Ann: Telix Q1 2024 Revenue and Business Update, page-130
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.80 |
Change
-0.450(2.47%) |
Mkt cap ! $5.947B | |||
| Open | High | Low | Value | Volume |
| $18.02 | $18.07 | $17.71 | $38.72M | 2.150M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 6519 | $17.78 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.81 | 293 | 1 |
View Market Depth
| Last trade - 16.10pm 04/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$17.78 |
Change
-0.450 ( 2.35 %) |
||||
| Open | High | Low | Volume | ||
| $17.99 | $18.07 | $17.71 | 313829 | ||
| Last updated 15.59pm 04/06/2024 ? | |||||
| TLX (ASX) Chart |